510(k) K252163

Elecsys Phospho-Tau (181P) Plasma by Roche Diagnostics — Product Code SET

K252163 is an FDA 510(k) premarket notification submitted by Roche Diagnostics for the device "Elecsys Phospho-Tau (181P) Plasma". The FDA issued a decision of Substantially Equivalent on Oct 8, 2025. The device falls under product code SET (Immunoassay Blood Test For Amyloid Pathology Assessment), a Class II device regulated under 21 CFR 866.5840. Roche Diagnostics has 456 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Oct 8, 2025
Date Received
Jul 10, 2025
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Immunoassay Blood Test For Amyloid Pathology Assessment
Device Class
Class II
Regulation Number
866.5840
Review Panel
IM
Submission Type
510(k)

An Immunoassay blood test for amyloid pathology assessment is an in vitro diagnostic test used to identify patients with amyloid pathology associated with Alzheimer’s Disease who have signs and symptoms of cognitive decline. The results of the test are to be interpreted in conjunction with other patient clinical information.

Need the full FDA record for Roche Diagnostics? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K252163. Report a data issue: hello@regdatalab.com.